Related Experiment Videos
Benzodiazepine hypnotics: sorting the pharmacokinetic facts
1Department of Pharmacology, Tufts University School of Medicine, Boston, MA 02111.
The Journal of Clinical Psychiatry
|September 1, 1991
Summary
Differences in how benzodiazepine drugs are absorbed, distributed, and cleared affect their clinical actions and side effects for sleep disorders. Understanding these pharmacokinetic and physicochemical properties helps predict patient outcomes.
Area of Science:
- Pharmacology
- Sleep Medicine
- Medicinal Chemistry
Background:
- Five benzodiazepine derivatives are approved for treating sleep disorders.
- These drugs exhibit significant variations in their physicochemical and pharmacokinetic profiles.
Purpose of the Study:
- To explore the physicochemical and pharmacokinetic differences among benzodiazepine hypnotics.
- To correlate these differences with observed clinical actions and side effects.
Main Methods:
- Review of physicochemical properties (lipid solubility, protein binding).
- Analysis of pharmacokinetic properties (absorption, distribution, elimination, clearance).
- Discussion of how these properties influence clinical effects.
Main Results:
- Significant inter-drug variability exists in lipid solubility and protein binding.
- Pharmacokinetic parameters like absorption rate, distribution volume, and clearance differ notably among benzodiazepines.
- These variations are linked to differences in efficacy and side effect profiles.
Conclusions:
- Physicochemical and pharmacokinetic properties are critical determinants of benzodiazepine hypnotic efficacy and safety.
- Understanding these drug-specific characteristics is essential for predicting treatment outcomes and managing side effects.